Showing results (2291-2300 of 4,401) with videos related to

Sort By:
Pageof 441
ACS Medicinal Chemistry Letters|March 19, 2025
Structural Studies of the Dopamine D4 Receptor Antagonist Sonepiprazole as an Inhibitor of Human Carbonic AnhydrasesAndrea Angeli, Marta Ferraroni, Clemente Capasso, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer TreatmentKun Xiao, Zheng Zhang, Yao Wu, et al.
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Cyclic Peptides Inhibiting Tumor Necrosis Factor Receptor 1 ActivityQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|May 4, 2013
From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational DesignLi-Fang Yu, Han-Kun Zhang, Hendra Gunosewoyo, et al.
ACS Medicinal Chemistry Letters|July 19, 2013
Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast CancerQuan Jiang, Qiu Zhong, Qiang Zhang, et al.
ACS Medicinal Chemistry Letters|June 25, 2013
Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate ReductoisomeraseJian Xue, Jiasheng Diao, Guobin Cai, et al.
ACS Medicinal Chemistry Letters|June 25, 2013
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate DehydrogenaseBaisong Zheng, Yuan Yao, Zhen Liu, et al.
ACS Medicinal Chemistry Letters|March 6, 2013
Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer AgentsHaijun Chen, Zhengduo Yang, Chunyong Ding, et al.
ACS Medicinal Chemistry Letters|April 23, 2013
3D-QSAR Assisted Design, Synthesis and Evaluation of Novobiocin AnaloguesHuiping Zhao, Elisabetta Moroni, Bin Yan, et al.
ACS Medicinal Chemistry Letters|March 30, 2013
Crown Ether Host-Rotaxanes as Cytotoxic AgentsDavid B Smithrud, Xiaoyang Wang, Pheruza Tarapore, et al.
Pageof 441